Genomic Screening can Help Detect Medullary Thyroid Cancer, Study Finds
Population-based genomic screening facilitates early detection of medullary thyroid cancer (MTC) in patients with variants in the RET gene.
Read MorePosted by Andy Lundin | Jan 26, 2023 | Unknown Origin & Other Cancer Types |
Population-based genomic screening facilitates early detection of medullary thyroid cancer (MTC) in patients with variants in the RET gene.
Read MorePosted by Andy Lundin | Jan 24, 2023 | Lung Cancer |
Thermo Fisher Scientific is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic test for Tagrisso.
Read MorePosted by Andy Lundin | Jan 24, 2023 | Diagnostic Technologies |
NanoMosaic established a scientific advisory board to help bring nanoneedle-powered digital proteomic tools to the diagnostic community.
Read MorePosted by Andy Lundin | Jan 23, 2023 | Sequencing Systems, Sexually Transmitted Diseases |
Thermo Fisher Scientific launched its Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, an assay that examines positive samples of HIV.
Read MorePosted by Andy Lundin | Jan 23, 2023 | Sequencing Systems |
QIAGEN Digital Insights unveiled their enhanced genomics workbench that removes the data-analysis bottleneck of next-generation sequencing.
Read More